Preoperative adjuvant therapy for locally advanced and recurrent/metastatic gastrointestinal stromal tumors: a retrospective study

BACKGROUND: Preoperative imatinib mesylate therapy for gastrointestinal stromal tumors (GISTs) is controversial. This study aimed to explore the clinical efficacy and optimal duration of preoperative imatinib mesylate (IM) therapy in patients with locally advanced and recurrent/metastatic GISTs. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Jing, Liu, He-Li, Ren, Feng, Liu, Sheng, Shi, Wei, Liu, Wei-Hang, Cai, Gao-Qiang, Liao, Guo-Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140320/
https://www.ncbi.nlm.nih.gov/pubmed/32264886
http://dx.doi.org/10.1186/s12957-020-01840-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140320/
https://www.ncbi.nlm.nih.gov/pubmed/32264886
http://dx.doi.org/10.1186/s12957-020-01840-9

Ejemplares similares